Thomas Shehab, Md, Mmm

Motif Neurotech is powered by innovations in efficient wireless power and data, unlocking possibilities for new, miniature implants for tissue stimulation and diagnostic readings.

At UpSkillAI, we believe training should feel as real—and be as impactful—as the work itself. That’s why we build AI-powered XR experiences that help people learn faster, retain more, and perform under pressure. Our team brings deep expertise from healthcare, military, and enterprise innovation, blending operational rigor with cutting-edge technology to deliver training that’s immersive, adaptive, and measurable. Whether you need a complete training platform or just one piece of the process, we provide a full-service solution that scales with you, from discovery and deployment to optimization and support. We serve clients across sectors, from hospitals and first responders to tech companies and government agencies. Delivering real-world results in the moments that matter most.

In 2014, an ER department physician shared his frustration with the inability of traditional vital signs to detect and predict patient destabilization that can lead to crisis. That challenged our team of nurses, physicians, and scientists to put the power of advanced signal processing and clinician supervised machine learning to work to break the code of the autonomic nervous system. The result was the AHI System – the only FDA-cleared clinical decision support device of its kind, predicting episodes of hemodynamic instability with clinically significant lead times, and giving care teams the time to plan and intervene to avoid a costly crisis, improve patient throughput and increase the overall effectiveness of telemetry monitoring. AHI, or Analytic for Hemodynamic Instability, was developed using artificial intelligence to see Heart Rate Variability (HRV), part of the autonomic nervous system (ANS). Fifth Eye discovered how to measure and interpret HRV data flow and ECG morphology features, predicting the hemodynamic risk that leads to acute decline in clinical status. Traditional vitals like blood pressure and pulse rate are “lagging indicators”, unable to see hours or days into the future to identify patients who may be at risk from compromised compensatory systems. AHI works on a single, noninvasive ECG lead II, displaying patient status updates every two minutes from anywhere in the hospital. There are no manual inputs, no new hardware and AHI is easy to adopt and use immediately. AHI is making a difference in the lives of patients and clinical teams – getting ahead of vitals to help patients on the brink of crisis receive care sooner and enhancing throughput to downgrade or discharge stable patients sooner. To learn more, visit FIFTHeye.com The AHI System is intended for use by healthcare professionals managing patients 18 years or older who are receiving continuous physiological monitoring with electrocardiography (ECG) in hospitals.

SonarMD is the leading value-based care coordination program for digestive health. We partner with health plans and providers to align incentives around proactive, cost-effective care for patients with chronic gut health conditions. Our holistic approach ensures timely access to expert support, personalized care pathways and the best innovations in GI care. We know chronic gut health conditions can be complex to predict, treat and manage. That’s why SonarMD is designed to proactively identify deteriorating symptoms — often before patients know there's a problem — enabling care teams to intervene faster and prevent complications. The result? We keep patients healthier and lower the overall cost of care. SonarMD is proven to engage 85% of patients, reduce ER visits and hospitalizations by 50% and drive 15% cost savings per member per year. #guthealth #digestivehealth #crohns #ulcerativecolitis #IBD #gastroenterology #healthplan #valuebasedcare

Aira (pronounced eye ruh) was founded in 2015 to uniquely address the needs of people who are blind or have low vision by providing access to visual information thereby providing independence and agency. Our mission is to remove barriers and make the world more accessible with visual interpreting. Whatever the reason, whatever the need, we provide access to visual information, anytime, anywhere. Initially, the AI in our name stood for Artificial Intelligence and the RA stood for Remote Assistance. Now with millions of calls to date, the importance of a human in the loop, providing access to information that is sometimes rather nuanced, is abundantly clear. We have reinterpreted the meaning of our name, AI now stands for Access to Information. Aira is visual interpreting, it’s access to information through remote assistance.

Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs). Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has the first end-to-end platform to discover, develop, and deliver PDTs to patients and a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA. Pear’s product, reSET®, for the treatment of substance use disorder, was the first PDT to receive marketing authorization from the FDA to treat disease. Pear’s second product, reSET-O®, for the treatment of opioid use disorder, was the first PDT to receive Breakthrough Designation. Pear’s third product, Somryst® for the treatment of chronic insomnia, was the first PDT submitted through FDA’s traditional 510(k) pathway while simultaneously reviewed through FDA’s Software Precertification Pilot Program. For more information, visit Pear at www.peartherapeutics.com.

Lucina delivers the leading women’s maternity analytics platform to innovative health plans, Medicaid providers, and public entities. Lucina identifies women at-risk of preterm birth, usually within the first trimester, with personalized health improvement resources, making it easy for care managers to complete actions that optimize the health and well-being of women to improve birth outcomes and to create healthier communities over time.

Motif Neurotech is powered by innovations in efficient wireless power and data, unlocking possibilities for new, miniature implants for tissue stimulation and diagnostic readings.

Virtual Incision is on a mission to simplify robotic-assisted surgery (RAS), so more patients and their surgeons can access its benefits every day. Headquartered in Lincoln, Nebraska, and holding over 200 patents and patent applications, the company is developing MIRA, the first-of-its-kind miniature, and highly accessible RAS platform. With MIRA, our goal is to make every operating room RAS-ready. MIRA is currently in FDA clinical trials under an Investigational Device Exemption (IDE) and is being studied first for bowel resection, with additional potential applications to follow. https://virtualincision.com

At UpSkillAI, we believe training should feel as real—and be as impactful—as the work itself. That’s why we build AI-powered XR experiences that help people learn faster, retain more, and perform under pressure. Our team brings deep expertise from healthcare, military, and enterprise innovation, blending operational rigor with cutting-edge technology to deliver training that’s immersive, adaptive, and measurable. Whether you need a complete training platform or just one piece of the process, we provide a full-service solution that scales with you, from discovery and deployment to optimization and support. We serve clients across sectors, from hospitals and first responders to tech companies and government agencies. Delivering real-world results in the moments that matter most.

In 2014, an ER department physician shared his frustration with the inability of traditional vital signs to detect and predict patient destabilization that can lead to crisis. That challenged our team of nurses, physicians, and scientists to put the power of advanced signal processing and clinician supervised machine learning to work to break the code of the autonomic nervous system. The result was the AHI System – the only FDA-cleared clinical decision support device of its kind, predicting episodes of hemodynamic instability with clinically significant lead times, and giving care teams the time to plan and intervene to avoid a costly crisis, improve patient throughput and increase the overall effectiveness of telemetry monitoring. AHI, or Analytic for Hemodynamic Instability, was developed using artificial intelligence to see Heart Rate Variability (HRV), part of the autonomic nervous system (ANS). Fifth Eye discovered how to measure and interpret HRV data flow and ECG morphology features, predicting the hemodynamic risk that leads to acute decline in clinical status. Traditional vitals like blood pressure and pulse rate are “lagging indicators”, unable to see hours or days into the future to identify patients who may be at risk from compromised compensatory systems. AHI works on a single, noninvasive ECG lead II, displaying patient status updates every two minutes from anywhere in the hospital. There are no manual inputs, no new hardware and AHI is easy to adopt and use immediately. AHI is making a difference in the lives of patients and clinical teams – getting ahead of vitals to help patients on the brink of crisis receive care sooner and enhancing throughput to downgrade or discharge stable patients sooner. To learn more, visit FIFTHeye.com The AHI System is intended for use by healthcare professionals managing patients 18 years or older who are receiving continuous physiological monitoring with electrocardiography (ECG) in hospitals.

SonarMD is the leading value-based care coordination program for digestive health. We partner with health plans and providers to align incentives around proactive, cost-effective care for patients with chronic gut health conditions. Our holistic approach ensures timely access to expert support, personalized care pathways and the best innovations in GI care. We know chronic gut health conditions can be complex to predict, treat and manage. That’s why SonarMD is designed to proactively identify deteriorating symptoms — often before patients know there's a problem — enabling care teams to intervene faster and prevent complications. The result? We keep patients healthier and lower the overall cost of care. SonarMD is proven to engage 85% of patients, reduce ER visits and hospitalizations by 50% and drive 15% cost savings per member per year. #guthealth #digestivehealth #crohns #ulcerativecolitis #IBD #gastroenterology #healthplan #valuebasedcare